<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Section 4.1 Overall Performance Summary &mdash; CytoAtlas Reports</title>
<style>
    :root {
        --bg: #ffffff;
        --fg: #1a1a2e;
        --accent: #2563eb;
        --accent-hover: #1d4ed8;
        --card-bg: #f8fafc;
        --card-border: #e2e8f0;
        --muted: #64748b;
    }
    * { margin: 0; padding: 0; box-sizing: border-box; }
    body {
        font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
        color: var(--fg);
        background: var(--bg);
        line-height: 1.6;
    }
    header {
        border-bottom: 1px solid var(--card-border);
        padding: 2rem 1.5rem 1.5rem;
        max-width: 960px;
        margin: 0 auto;
    }
    header h1 { font-size: 1.8rem; font-weight: 700; }
    header p { color: var(--muted); margin-top: 0.25rem; }
    main {
        max-width: 960px;
        margin: 0 auto;
        padding: 2rem 1.5rem 4rem;
    }
    footer {
        max-width: 960px;
        margin: 0 auto;
        padding: 1rem 1.5rem;
        border-top: 1px solid var(--card-border);
        font-size: 0.8rem;
        color: var(--muted);
    }

    /* Navigation */
    .back-link {
        display: inline-block;
        margin-bottom: 1.5rem;
        padding: 0.35em 0.75em;
        background: var(--card-bg);
        border: 1px solid var(--card-border);
        border-radius: 6px;
        font-size: 0.85rem;
        color: var(--accent);
        text-decoration: none;
        transition: border-color 0.15s;
    }
    .back-link:hover { border-color: var(--accent); }

    /* Headings */
    h2 {
        font-size: 1.4rem;
        margin: 2.5rem 0 1rem;
        padding-bottom: 0.5rem;
        border-bottom: 2px solid var(--accent);
    }
    h3 { font-size: 1.1rem; margin: 1.5rem 0 0.6rem; color: var(--accent); }
    p { margin-bottom: 0.75rem; }
    a { color: var(--accent); text-decoration: none; }
    a:hover { text-decoration: underline; }

    /* Tables */
    table { width: 100%; border-collapse: collapse; margin: 1rem 0 1.25rem; font-size: 0.875rem; }
    th, td { padding: 0.6rem 0.85rem; text-align: left; border: 1px solid var(--card-border); }
    th { background: var(--card-bg); font-weight: 600; }
    tr:hover { background: var(--card-bg); }

    /* Code */
    code {
        background: var(--card-bg);
        border: 1px solid var(--card-border);
        padding: 0.15em 0.4em;
        border-radius: 4px;
        font-size: 0.85rem;
        font-family: 'JetBrains Mono', 'Fira Code', ui-monospace, monospace;
    }

    /* Significance markers */
    .sig { font-weight: bold; }
    .sig-yes { color: #059669; }
    .sig-no { color: var(--muted); }

    /* Lists */
    ul, ol { margin: 0.5rem 0 1rem 1.5rem; }
    li { margin-bottom: 0.4rem; }

    .page-title {
        font-size: 1.6rem;
        font-weight: 700;
        margin-top: 0;
        margin-bottom: 1.5rem;
    }

    /* Method color coding */
    .method-cytosig { background-color: #DBEAFE; }
    .method-lincytosig { background-color: #FEF3C7; }
    .method-secact { background-color: #D1FAE5; }
</style>
</head>
<body>

<header>
    <h1>CytoAtlas Reports</h1>
    <p>Pan-Disease Single-Cell Cytokine Activity Atlas &mdash; reporting hub</p>
</header>

<main>

<a href="index.html" class="back-link">&larr; Back to report</a>

<div class="page-title">Section 4.1: Overall Performance Summary &mdash; Full Details</div>

<h2>Overview</h2>
<p>Section 4.1 provides the definitive CytoSig vs SecAct summary across 6 datasets at each dataset&rsquo;s primary independent level. This supplement includes all aggregation levels (not just the primary independent level shown in the main report).</p>

<h2>Independence-Corrected Methodology</h2>
<p>All correlations use a <strong>median-of-medians</strong> approach to ensure statistical independence:</p>
<ul>
<li><strong>GTEx (by_tissue, 29 tissues)</strong>: Each target&rsquo;s representative &rho; = median of its per-tissue Spearman &rho; values across 29 tissues.</li>
<li><strong>TCGA (primary_by_cancer, 33 cancer types)</strong>: Same median-of-medians approach across 33 cancer types.</li>
<li><strong>CIMA, Inflammation Atlas Main, scAtlas Normal, scAtlas Cancer</strong>: Each target has one &rho; at the donor/tumor level (no tissue/cancer stratification needed), so no median-of-medians aggregation is required.</li>
</ul>
<p><strong>% Sig</strong>: Benjamini&ndash;Hochberg FDR correction (q &lt; 0.05) applied within each dataset &times; method group.</p>

<h2>Primary Independent Level Summary</h2>
<table>
<tr>
    <th>Dataset</th>
    <th>Method</th>
    <th>N Targets</th>
    <th>Median &rho;</th>
    <th>% Sig (BH q&lt;0.05)</th>
    <th>% Pos</th>
</tr>
<tr class="method-cytosig">
    <td>GTEx (by_tissue)</td>
    <td>CytoSig</td>
    <td>43</td>
    <td>0.151</td>
    <td>81.4%</td>
    <td>83.7%</td>
</tr>
<tr class="method-secact">
    <td>GTEx (by_tissue)</td>
    <td>SecAct</td>
    <td>1,132</td>
    <td>0.314</td>
    <td>88.8%</td>
    <td>90.5%</td>
</tr>
<tr class="method-cytosig">
    <td>TCGA (primary_by_cancer)</td>
    <td>CytoSig</td>
    <td>41</td>
    <td>0.214</td>
    <td>68.3%</td>
    <td>92.7%</td>
</tr>
<tr class="method-secact">
    <td>TCGA (primary_by_cancer)</td>
    <td>SecAct</td>
    <td>1,085</td>
    <td>0.357</td>
    <td>81.5%</td>
    <td>95.8%</td>
</tr>
<tr class="method-cytosig">
    <td>CIMA (donor_only)</td>
    <td>CytoSig</td>
    <td>43</td>
    <td>0.114</td>
    <td>69.8%</td>
    <td>58.1%</td>
</tr>
<tr class="method-secact">
    <td>CIMA (donor_only)</td>
    <td>SecAct</td>
    <td>1,161</td>
    <td>0.191</td>
    <td>75.0%</td>
    <td>76.1%</td>
</tr>
<tr class="method-cytosig">
    <td>Inflammation Atlas Main (donor_only)</td>
    <td>CytoSig</td>
    <td>33</td>
    <td>0.323</td>
    <td>78.8%</td>
    <td>69.7%</td>
</tr>
<tr class="method-secact">
    <td>Inflammation Atlas Main (donor_only)</td>
    <td>SecAct</td>
    <td>805</td>
    <td>0.173</td>
    <td>84.8%</td>
    <td>72.7%</td>
</tr>
<tr class="method-cytosig">
    <td>scAtlas Normal (donor_only)</td>
    <td>CytoSig</td>
    <td>43</td>
    <td>0.173</td>
    <td>74.4%</td>
    <td>69.8%</td>
</tr>
<tr class="method-secact">
    <td>scAtlas Normal (donor_only)</td>
    <td>SecAct</td>
    <td>1,140</td>
    <td>0.455</td>
    <td>83.9%</td>
    <td>87.8%</td>
</tr>
<tr class="method-cytosig">
    <td>scAtlas Cancer (tumor_only)</td>
    <td>CytoSig</td>
    <td>43</td>
    <td>0.184</td>
    <td>81.4%</td>
    <td>83.7%</td>
</tr>
<tr class="method-secact">
    <td>scAtlas Cancer (tumor_only)</td>
    <td>SecAct</td>
    <td>1,140</td>
    <td>0.399</td>
    <td>92.3%</td>
    <td>95.0%</td>
</tr>
</table>

<h2>Supplementary Aggregation Levels</h2>
<p>The primary independent levels above represent the statistically rigorous comparison. Below are <strong>additional aggregation levels</strong> shown for completeness. These fall into two categories:</p>
<ul>
<li><strong>Pooled levels</strong> &mdash; aggregate across tissues or cancer types, inflating correlations through confounding (e.g., GTEx <code>donor_only</code> pools 29 tissues per donor).</li>
<li><strong>Finer cell-type levels</strong> &mdash; stratify by cell type within donors, typically reducing correlations as pseudobulk groups shrink and noise increases.</li>
</ul>

<h3>Pooled Levels (may inflate correlations)</h3>
<p style="color:#b91c1c;font-size:0.9rem;"><strong>Caution:</strong> These levels pool across tissues or cancer types. Higher correlations reflect confounding by tissue/cancer composition, not better inference. Use the primary independent levels above for method comparison.</p>
<table>
<tr>
    <th>Dataset (Level)</th>
    <th>Method</th>
    <th>N Targets</th>
    <th>Median &rho;</th>
    <th>% Sig (BH q&lt;0.05)</th>
    <th>% Pos</th>
    <th>Independence Issue</th>
</tr>
<tr class="method-cytosig">
    <td>GTEx (donor_only)</td>
    <td>CytoSig</td>
    <td>43</td>
    <td>0.211</td>
    <td>100.0%</td>
    <td>81.4%</td>
    <td rowspan="2">Pools 29 tissues per donor &mdash; tissue-level confounding</td>
</tr>
<tr class="method-secact">
    <td>GTEx (donor_only)</td>
    <td>SecAct</td>
    <td>1,132</td>
    <td>0.394</td>
    <td>98.3%</td>
    <td>90.0%</td>
</tr>
<tr class="method-cytosig">
    <td>TCGA (donor_only)</td>
    <td>CytoSig</td>
    <td>41</td>
    <td>0.238</td>
    <td>92.7%</td>
    <td>92.7%</td>
    <td rowspan="2">Pools 33 cancer types &mdash; cancer-type confounding</td>
</tr>
<tr class="method-secact">
    <td>TCGA (donor_only)</td>
    <td>SecAct</td>
    <td>1,085</td>
    <td>0.415</td>
    <td>99.2%</td>
    <td>97.1%</td>
</tr>
<tr class="method-cytosig">
    <td>scAtlas Normal (donor_organ)</td>
    <td>CytoSig</td>
    <td>43</td>
    <td>0.097</td>
    <td>2.3%</td>
    <td>79.1%</td>
    <td rowspan="2">Multiple organs per donor &mdash; organ-level confounding</td>
</tr>
<tr class="method-secact">
    <td>scAtlas Normal (donor_organ)</td>
    <td>SecAct</td>
    <td>1,140</td>
    <td>0.279</td>
    <td>24.8%</td>
    <td>91.1%</td>
</tr>
<tr class="method-cytosig">
    <td>scAtlas Cancer (donor_only)</td>
    <td>CytoSig</td>
    <td>43</td>
    <td>0.218</td>
    <td>83.7%</td>
    <td>83.7%</td>
    <td rowspan="2">Pools cancer types per donor</td>
</tr>
<tr class="method-secact">
    <td>scAtlas Cancer (donor_only)</td>
    <td>SecAct</td>
    <td>1,140</td>
    <td>0.390</td>
    <td>92.7%</td>
    <td>95.5%</td>
</tr>
</table>
<p><strong>Inflation magnitude:</strong> GTEx pooled CytoSig (0.211) is 40% higher than the independent by_tissue level (0.151). TCGA pooled (0.238) is 11% higher than primary_by_cancer (0.214). SecAct shows similar inflation: GTEx 0.394 vs 0.314 (+25%), TCGA 0.415 vs 0.357 (+16%).</p>

<h3>Finer Cell-Type Levels (reduced signal from smaller pseudobulk groups)</h3>
<p>Stratifying by cell type within donors produces smaller pseudobulk groups, typically reducing correlations as noise increases. These levels answer a different question: &ldquo;does the activity-expression relationship hold at per-cell-type resolution?&rdquo;</p>
<table>
<tr>
    <th>Dataset (Level)</th>
    <th>Method</th>
    <th>N Targets</th>
    <th>Median &rho;</th>
    <th>% Sig (BH q&lt;0.05)</th>
    <th>% Pos</th>
</tr>
<tr class="method-cytosig"><td>CIMA (donor_l1)</td><td>CytoSig</td><td>43</td><td>0.049</td><td>51.2%</td><td>67.4%</td></tr>
<tr class="method-secact"><td>CIMA (donor_l1)</td><td>SecAct</td><td>1,161</td><td>0.133</td><td>71.2%</td><td>79.8%</td></tr>
<tr class="method-cytosig"><td>CIMA (donor_l2)</td><td>CytoSig</td><td>43</td><td>0.024</td><td>18.6%</td><td>62.8%</td></tr>
<tr class="method-secact"><td>CIMA (donor_l2)</td><td>SecAct</td><td>1,161</td><td>0.081</td><td>42.9%</td><td>83.7%</td></tr>
<tr class="method-cytosig"><td>CIMA (donor_l3)</td><td>CytoSig</td><td>43</td><td>0.021</td><td>18.6%</td><td>58.1%</td></tr>
<tr class="method-secact"><td>CIMA (donor_l3)</td><td>SecAct</td><td>1,161</td><td>0.068</td><td>25.2%</td><td>84.1%</td></tr>
<tr class="method-cytosig"><td>CIMA (donor_l4)</td><td>CytoSig</td><td>43</td><td>0.009</td><td>16.3%</td><td>55.8%</td></tr>
<tr class="method-secact"><td>CIMA (donor_l4)</td><td>SecAct</td><td>1,161</td><td>0.049</td><td>9.7%</td><td>81.4%</td></tr>
<tr class="method-cytosig"><td>Inflammation Atlas Main (donor_l1)</td><td>CytoSig</td><td>33</td><td>0.074</td><td>69.7%</td><td>63.6%</td></tr>
<tr class="method-secact"><td>Inflammation Atlas Main (donor_l1)</td><td>SecAct</td><td>805</td><td>0.082</td><td>75.4%</td><td>71.7%</td></tr>
<tr class="method-cytosig"><td>Inflammation Atlas Main (donor_l2)</td><td>CytoSig</td><td>33</td><td>0.037</td><td>51.5%</td><td>66.7%</td></tr>
<tr class="method-secact"><td>Inflammation Atlas Main (donor_l2)</td><td>SecAct</td><td>805</td><td>0.046</td><td>42.4%</td><td>64.8%</td></tr>
<tr class="method-cytosig"><td>scAtlas Normal (donor_organ_celltype1)</td><td>CytoSig</td><td>43</td><td>0.076</td><td>0.0%</td><td>69.8%</td></tr>
<tr class="method-secact"><td>scAtlas Normal (donor_organ_celltype1)</td><td>SecAct</td><td>1,140</td><td>0.143</td><td>0.0%</td><td>95.0%</td></tr>
<tr class="method-cytosig"><td>scAtlas Normal (donor_organ_celltype2)</td><td>CytoSig</td><td>43</td><td>0.018</td><td>0.0%</td><td>65.1%</td></tr>
<tr class="method-secact"><td>scAtlas Normal (donor_organ_celltype2)</td><td>SecAct</td><td>1,140</td><td>0.112</td><td>0.0%</td><td>94.3%</td></tr>
<tr class="method-cytosig"><td>scAtlas Cancer (tumor_by_cancer)</td><td>CytoSig</td><td>43</td><td>0.174</td><td>16.3%</td><td>79.1%</td></tr>
<tr class="method-secact"><td>scAtlas Cancer (tumor_by_cancer)</td><td>SecAct</td><td>1,140</td><td>0.340</td><td>43.0%</td><td>92.5%</td></tr>
<tr class="method-cytosig"><td>scAtlas Cancer (tumor_by_cancer_celltype1)</td><td>CytoSig</td><td>43</td><td>0.022</td><td>0.0%</td><td>58.1%</td></tr>
<tr class="method-secact"><td>scAtlas Cancer (tumor_by_cancer_celltype1)</td><td>SecAct</td><td>1,140</td><td>0.151</td><td>3.4%</td><td>94.5%</td></tr>
</table>
<p><strong>Pattern:</strong> Correlations decrease monotonically with finer resolution. CIMA CytoSig drops from 0.114 (donor_only) &rarr; 0.049 (L1) &rarr; 0.024 (L2) &rarr; 0.021 (L3) &rarr; 0.009 (L4). SecAct maintains higher correlations than CytoSig at every level, suggesting broader gene coverage provides more robust signal even in small pseudobulk groups.</p>

<h2>Supplementary Datasets</h2>
<p><strong>Inflammation Atlas Val</strong> (144 samples) and <strong>Inflammation Atlas Ext</strong> (86 samples) replicate directionally. Full results are available in the validation correlation CSVs.</p>

<h2>Software</h2>
<p>All statistics computed using Python <code>scipy.stats</code> (Spearman correlations) and <code>statsmodels.stats.multitest</code> (Benjamini&ndash;Hochberg FDR correction).</p>

</main>

<footer>
    CytoAtlas &mdash; generated reports are served via GitHub Pages
</footer>

</body>
</html>
